Advertisement

Topics

Latest "Lexi-Comp, Inc." News Stories

13:35 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Lexi-Comp, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Lexi-Comp, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Lexi-Comp, Inc. for you to read. Along with our medical data and news we also list Lexi-Comp, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Lexi-Comp, Inc. Companies for you to search.

Showing "Lexi Comp" News Articles, all 24

Wednesday 13th March 2019

Active Biotech has entered into an agreement regarding sale of the Company's property - extraordinary general meeting on April 4, 2019

  Lund Sweden, March 13 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that Active Biotech has entered into an agreement regarding sale of the Company's property Forskaren 1 in Lund, Sweden, with a newly formed investor collective led by the real estate company Estea AB. The purchase price amounts to SEK 275 million. Active Biotech AB (publ) indirectly owns the pro...


Health Strategy Associates’ Joe Paduda to Discuss the Impact of “Medicare for All” on Work Comp in Keynote Address to CSIA

Joe Paduda, principal of Health Strategy Associates, will deliver the keynote address at the California Self Insurer Association (CSIA) 2019 Employer Seminar and Educational Conference, kicking off the conference at 1:30 p.m. on April 8. Paduda will explore the potential for the adoption of a single payer health plan in California and what that would mean ...

Friday 15th February 2019

NSAIDs Overtake Opioids As The Top Workers’ Comp Drug Group; Dermatologicals Are Most Costly

A new California Workers’ Compensation Institute (CWCI) study finds that non-steroidal anti-inflammatories (NSAIDs) have supplanted opioids as the most common therapeutic drug group prescribed to injured workers in California, while payment data show that both dermatological medications and anticonvulsants now rank ahead of opioids in terms of total reim...


Wednesday 13th February 2019

Dyadic International, Inc.: Dyadic Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ

JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange Commission (the "SEC") has declared the Comp...

Friday 25th January 2019

International Cannabrands Inc.: International Cannabrands Announces Fourth and Largest Closing of Brokered Financing Co-Led by Gravitas Securities and Canaccord Genuity

Not for dissemination to United States newswire services or for dissemination in the United States CALGARY, AB / ACCESSWIRE / January 25, 2019 / International Cannabrands Inc. (CSE:JUJU) (the "Comp...

Monday 21st January 2019

Xybion Partners with Northwell Health to Manage Its Workforce Safety Using Xybion’s Emidence™ Cloud

Xybion Corporation announced today it is partnering with Northwell Health to strengthen workforce safety at its hospitals and outpatient facilities. New York State’s largest health care provider and private employer with 23 hospitals, more than 700 ambulatory locations and a workforce of about 68,000 (including 15,000-plus nurses and about 4,000 employed...

Thursday 17th January 2019

Silence’s SLN124 gets orphan designation in Europe for β-Thalassemia

The designation to SLN124 was granted by the Committee for Orphan Medicinal Products (COMP), a committee of the European Medicines Agency (EMA). COMP after reviewing an application filed The post Silence’s SLN124 gets orphan designation in Europe for β-Thalassemia appeared first on Pharmaceutical Business review.

Wednesday 16th January 2019

Method Insurance Services Announces New Specialty Workers' Comp Program

Method Insurance Services is excited to launch a Specialty Workers’ Compensation program with Service American Indemnity Company that focuses on an under-served market segment for challenging, high-hazard risks. The program will entertain middle market accounts with manual premiums between $10,000 - $250,000 that include a broad range of class codes with...

Friday 11th January 2019

AbelsonTaylor Launches ICONS.HEALTH™, a Content Channel Exploring Innovation at the Intersection of Healthcare and Technology

Innovators and Entrepreneurs from Health-Tech Startups to Global Corporations Provide Insights in Casual Conversations about Serious Topics What do Microsoft, Aetna, Twitter, IBM, Ogilvy Consulting, Biogen and dozens of healthcare startups have in common? All appear in discussions about issues at the nexus of healthcare and technology in Icons.Health...

Tuesday 11th December 2018

Improved understanding of the pathology of dwarfism may lead to new treatment targets

(Elsevier) Pseudoachondroplasia (PSACH) is a severe inherited dwarfing condition In PSACH, a genetic mutation leads to abnormal retention of cartilage oligomeric matrix protein (COMP) within the endoplasmic reticulum (ER) of cartilage-producing cells (chondrocytes), which interferes with function and cell viability. In a report in The American Journal of Pathology, investigators describe how this ...

MedRisk’s 2018 Industry Trends Report Points to Conservative Care

While workers’ compensation claims frequency and occupational injury rates have declined over the past few years, the number of claims involving physical and/or occupational therapy rose by 13 percent, according to MedRisk’s 2018 Industry Trends Report on Physical Medicine and Workers’ Comp. Several factors contributed to the increased use of physica...

Tuesday 4th December 2018

Scholar Rock Announces Positive Opinion by the European Medicines Agency

Scholar Rock (NASDAQ:SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the European Medicines Agency’s (EMA’s) Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion recommending SRK-015 (human anti-promyostatin monoclonal antibody) for designation a...

Wednesday 14th November 2018

Wholehearted Besties that Never Betray You: aPure Introduces Pure5.5 Underwear as Your Intimate BFF

The World Health Organization warns 85% of women's recurrent gynecological diseases can be linked to the underwear! No wonder it’s said “the one be closest to you can hurt you the most.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181114005031/en/

Tuesday 13th November 2018

Novocure Announces More than 70 Presentations on Tumor Treating Fields at 23rd Annual Meeting of the Society for Neuro-Oncology

Presentations span 21 research areas with five oral presentations More than 50 presentations from external authors indicate a growing interest Novocure’s proprietary Tumor Treating Fields platform Novocure (NASDAQ: NVCR) today announced more than 70 presentations on Tumor Treating Fields, including five oral presentations, will be ...

Friday 9th November 2018

Woman, 27, who lost a staggering 303lbs has surgery to remove 7lbs of excess skin that was causing agonising pain in … – Daily Mail

Daily MailWoman, 27, who lost a staggering 303lbs has surgery to remove 7lbs of excess skin that was causing agonising pain in ...Daily MailA woman has had surgery to remove 7lbs (3.2kg) of excess skin after she lost a staggering 303lbs (137.4kg). Lexi Reed, 27, from Terre Haute, Indiana, who used to weigh 490lbs (222.2kg), was left with severe folds of loose skin after she shed more than ...and m...

Tuesday 6th November 2018

WesternU Honors Friends Old and New as Students Shine

More than 600 guests at “A Tribute to Caring,” held Nov. 3, 2018 at the Disneyland Hotel in Anaheim, California, helped Western University of Health Sciences raise money for student scholarships. The University honored osteopathic pioneer and one of its founders, Ethan Allen, DO, as well as entrepreneur Leo Chu. ANAHEIM, Calif. (PRWEB) November 06, 2018 Western University of Health Sciences...

Tuesday 30th October 2018

MALARIA BREAKTHROUGH: Sniffer dogs trained to detect disease in children – Express.co.uk

Express.co.ukMALARIA BREAKTHROUGH: Sniffer dogs trained to detect disease in childrenExpress.co.ukLabrador Sally, golden retriever cross Lexi and Freya, a spring spaniel, have been trained to use their super sensitive smell to detect odours given off by children suffering from the disease which kills more than 450,000 annually. The animals from ...Dogs can detect malaria by sniffing people's socks...

Monday 29th October 2018

Workers' Comp Often a Gateway to Opioid Abuse: Study

MONDAY, Oct. 29, 2018 -- Many injured workers turn to opioid painkillers for relief, and nearly 30 percent may still be taking them three months after their injury -- increasing the odds of addiction, a new study suggests. "The increased likelihood...

Tuesday 16th October 2018

EMA's COMP issues positive opinion on orphan drug status for Santhera's POL6014 to treat cystic fibrosis

Santhera Pharmaceuticals has announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on orphan drug designation for POL6014

Wednesday 26th September 2018

MÄRKTE USA/Börse vor Fed-Entscheid im Plus - Hohe Kosten belasten Nike

NEW YORK (Dow Jones)--Bis zum Mittag (Ortszeit New York) bauen die US-Börsen ihre Gewinne noch etwas aus. Der Dow-Jones-Index gewinnt 0,2 Prozent auf 26.543 Punkte. Der S&P-500 und der Nasdaq-Comp...

Thursday 13th September 2018

SELLAS Receives Orphan Medicinal Product Designation Approval by the Committee for Orphan Medicinal Products of the European Medicines Agency

SELLAS Life Sciences Group (Nasdaq:SLS) a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has approved orphan medicinal product designation (OMPD) for galinpepimut-S (GPS), the Company’s lead pr...

News and press releases: Committee for Orphan Medicinal Products (COMP) elects new chair

Violeta Stoyanova-Beninska to begin three-year mandate at October meeting

Monday 10th September 2018

CWCI Analysis Finds California Workers’ Comp IMR Volume Has Increased in 2018

The number of independent medical reviews (IMRs) used to resolve California workers’ compensation medical disputes rose 4.4 percent in the first half of 2018 compared to the first half of 2017, though once again in more than 90 percent of the cases the independent medical review physician upheld the utilization review physician’s modification or denial...

Thursday 23rd August 2018

Health Wonk Review is up at Workers’ Comp Insider

It’s time for the Waning days of summer edition of the Health Wonk Review, hosted by Julie Ferguson at Workers’ Comp Insider. Go check it out. Although I have not had time for a lot of blogging this summer (waning days or otherwise) one of my posts and one videocast that includes me are featured. The post Health Wonk Review is up at Workers’ Comp Insider appeared first on Health ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks